Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2025-05-14 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying about a scheduled Board of Directors meeting to consider and approve audited financial statements and financial results for the fiscal year ended March 31, 2025. It also mentions the closure of the trading window as per insider trading regulations. The document is an announcement of an upcoming board meeting and financial results approval, not the financial report itself. The document length is short (2034 characters) and does not contain actual financial data or detailed financial statements. Therefore, it is not an Annual Report (10-K) or Interim Report (IR), but rather a Regulatory Filing (RNS) notifying about the board meeting and related compliance matters under SEBI regulations.
2025-05-14 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the completion of an investment in a wholly owned subsidiary. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about material events or information. The content is an update on a capital investment transaction, specifically the completion of an investment in equity shares. The document length is only 1905 characters, indicating it is a brief announcement rather than a detailed report. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not an annual or interim report, audit report, or any other detailed financial or governance document. Therefore, the correct classification is CAP with high confidence.
2025-05-08 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-29 English
Change in Auditors
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the appointment of a Cost Auditor for the fiscal year 2025-26. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and includes details about the appointment as per SEBI circular. The content is an announcement of a board decision regarding auditor appointment, not a financial report or detailed audit report. The document length is under 5,000 characters and it serves as an intimation to the exchanges rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-04-28 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-19 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.